blank Quick help
blank Maintenance news
blank News flashes
blank Related links

Extract from the Register of European Patents

EP About this file: EP0278776

EP0278776 - Methods and deoxyribonucleic acid for the preparation of tissue factor protein [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  27.02.2004
Database last updated on 05.04.2025
Most recent event   Tooltip05.10.2005Change: Appeal number 
Applicant(s)For all designated states
Genentech, Inc.
460 Point San Bruno Boulevard
South San Francisco CA 94080 / US
[N/P]
Inventor(s)01 / Lawn, Richard Mark
1927 8th Avenue
San Francisco, CA 94116 / US
02 / Wion, Karen Lynne
663 Santa Barbara Avenue
Millbrae, CA 94030 / US
03 / Vehar, Gorden Allen
110 Leslie Drive
San Carlos, CA 94070 / US
[1997/22]
Representative(s)Miles, John Stephen, et al
Potter Clarkson LLP The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
[N/P]
Application number, filing date88301190.012.02.1988
[1988/33]
Priority number, dateUS1987001374312.02.1987         Original published format: US 13743
US1987003540907.04.1987         Original published format: US 35409
US1988015269805.02.1988         Original published format: US 152698
[1988/33]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0278776
Date:17.08.1988
Language:EN
[1988/33]
Type: A3 Search report 
No.:EP0278776
Date:13.09.1989
Language:EN
[1989/37]
Type: B1 Patent specification 
No.:EP0278776
Date:28.05.1997
Language:EN
[1997/22]
Type: B2 New European patent specification 
No.:EP0278776
Date:14.04.2004
Language:EN
[2004/16]
Search report(s)(Supplementary) European search report - dispatched on:EP26.07.1989
ClassificationIPC:C12N15/12, C07K14/745, C12N5/10, C12N1/21
[1997/22]
CPC:
C12N15/85 (EP); A61P7/04 (EP); C07K14/005 (EP);
C07K14/475 (EP); C07K14/745 (EP); C12N9/6429 (EP); (+)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1988/33]
TitleGerman:Verfahren und Desoxyribonukleinsäure zur Herstellung von Gewebefaktor-Protein[1988/33]
English:Methods and deoxyribonucleic acid for the preparation of tissue factor protein[1988/33]
French:Méthodes et acide desoxyribonucléique pour la préparation de la protéine du facteur tissulaire[1988/33]
MiscellaneousEPB 2004/16: (deleted)
EPB 2004/16: (deleted)
EPB 2004/16: (deleted)
EPB 1997/15: Teilanmeldung 97200009.5 eingereicht am 03/01/97
EPB 1997/15: Divisional application 97200009.5 filed on 03/01/97
EPB 1997/15: Demande divisionnaire 97200009.5 déposée le 03/01/97
Examination proceduredeletedDecision about request for accelerated examination - accepted: No
03.03.1990Examination requested  [1990/18]
05.06.1992Despatch of a communication from the examining division (Time limit: M06)
15.01.1993Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
17.03.1993Reply to a communication from the examining division
04.10.1993Despatch of a communication from the examining division (Time limit: M06)
12.04.1994Reply to a communication from the examining division
16.06.1994Despatch of a communication from the examining division (Time limit: M04)
20.10.1994Reply to a communication from the examining division
18.01.1995Request for accelerated examination filed
16.02.1995Despatch of a communication from the examining division (Time limit: M04)
08.06.1995Reply to a communication from the examining division
24.07.1995Despatch of a communication from the examining division (Time limit: M02)
05.09.1995Reply to a communication from the examining division
04.12.1995Despatch of a communication from the examining division (Time limit: M06)
12.06.1996Reply to a communication from the examining division
19.12.1996Despatch of communication of intention to grant (Approval: Yes)
14.01.1997Communication of intention to grant the patent
21.03.1997Fee for grant paid
21.03.1997Fee for publishing/printing paid
Divisional application(s)EP97200009.5  / EP0787802
Opposition(s)Opponent(s)01  23.02.1998   
Diagnostica Stago
9, rue des Frères Chausson BP 226
92602 Asnieres / FR
Opponent's representative
Robert, Jean-Pierre
Cabinet Boettcher 16, rue Médéric
75017 Paris / FR
 02  27.02.1998    ADMISSIBLE
The Scripps Research Institute
10666 North Torrey Pines Road
La Jolla, California 92037 / US
Opponent's representative
Vossius, Volker
ZSP Patentanwälte PartG mbB
Radlkoferstrasse 2
81373 München / DE
 [N/P]
07.04.1998Invitation to proprietor to file observations on the notice of opposition
27.11.1998Reply of patent proprietor to notice(s) of opposition
16.05.2000Date of oral proceedings
29.06.2000Despatch of a communication from the opposition division (Time limit: M02)
29.06.2000Despatch of minutes of oral proceedings
22.08.2000Reply to a communication from the opposition division
29.01.2001Despatch of interlocutory decision in opposition
02.07.2003Legal effect of interlocutory decision in opposition
14.11.2003Despatch of communication that the patent will be maintained as amended
05.02.2004Fee for printing new specification paid
Appeal following opposition20.03.2001Appeal received No.  T0351/01
08.06.2001Statement of grounds filed
02.07.2003Result of appeal procedure: maintenance in amended form
02.07.2003Date of oral proceedings
09.07.2003Minutes of the oral proceedings despatched
Request for further processing for:17.03.1993Request for further processing filed
17.03.1993Full payment received (date of receipt of payment)
Request granted
02.04.1993Decision despatched
Fees paidRenewal fee
18.01.1990Renewal fee patent year 03
21.01.1991Renewal fee patent year 04
20.01.1992Renewal fee patent year 05
08.02.1993Renewal fee patent year 06
25.02.1994Renewal fee patent year 07
24.02.1995Renewal fee patent year 08
26.02.1996Renewal fee patent year 09
26.02.1997Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]EP0139416  (GENENTECH INC [US]);
 [E]WO8809817  (SINAI SCHOOL MEDICINE [US], et al)
    [ ] - Thrombosis and Haemostasis, Vol. 58, No. 1, January 1987, page 258, Ref. No. 941; Stuttgart, DE, T.S. EDGINGTON et al.: "Molecular cloning of human tissue factor cDNA", Abstract.
    [ ] - Proc. Natl. Acad. Sci. USA, Vol. 83, January 1986, Biochemistry, pages 299-302; Washington, US, A. GUHA et al.: "Affinity purification of human tissue factor: Interaction of factor VII and tissue factor in detergent micelles", whole article.
    [ ] - Federation Proceedings, Vol. 46, No. 3, March 1, 1987, page 716, Ref. No. 2338; Bethesda, US, J.H. MORRISSEY et al.: "Molecular cloning of the cDNA for human tissue factor", Abstract.
    [ ] - Federation Proceedings, Vol. 46, No. 6, May 1, 1987, page 2242, Ref. No. 1846, Bethesda, US, E.M. SCARPATI et al.: "Human tissue factor: Cona cloning, primary structure, and chromosome localization", Abstract.
    [ ] - Cell, Vol. 50, July 3, 1987, pages 129-135; Cambridge, US, J.H. MORRISSEY et al.: "Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade", whole article.
    [ ] - Biochemistry, Vol. 26, No. 17, August 25, 1987, pages 5234-5238; Washington, US, E.M. SCARPATI et al.: "Human tissue factor: cDNA sequence and chromosome localization of the gene", whole article.
    [ ] - Proc. Natl. Acad. Sci. USA, Vol. 84, No. 15, August 1987, pages 5148-5152; Washington, US, E.K. SPICER et al.: "Isolation of cDNA clones coding for human tissue factor: Primary structure of the protein and cDNA", whole article.
    [ ] - Thrombosis Research, Vol. 48, No. 1, October 1987, pages 89-99; New York, US, K.L. FISHER et al.: "Cloning and expression of human tissue factor cDNA", whole article.
    [ ] - Federation Proceedings, Vol. 45, No. 6, May 1986, page 1639, Ref. No. 927; Bethesda, US, J.M. KITTLER et al.: "Identification of a cDNA clone for bovine tissue factor", Abstract.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.